SARS-COV-2 Vaccinations in RMD patients
The EULAR Task Force on COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021).
The information addresses questions, including considerations regarding vaccination effectiveness and safety, the third vaccination dose, booster vaccination, combination with Influenza and Pneumococcus vaccination, among other frequently asked questions by people with RMDs.
EULAR President, Prof Annamaria Iagnocco, invites you to share the link with your axSpA community.
Other NEWS
Webinar: HCP Education
Monday 19 May at 14:00-15:00 BST Register Now The global delay to …
Read More
The Pursuit of Remission and Improved Quality of Life in axSpA
Join the Global Alliance for Patient Access (GAfPA) and ASIF’s …
Read More